July 2015

“Now that we know that sequencing these resistant cancers can nominate novel therapies, we think we are entering a new era of personalized therapeutic decision making for children with currently incurable disease.”- John Maris, MD

Researchers Pinpoint Mutations in Relapsed Neuroblastoma


An international collaboration of researchers has identified several progressive series of mutations that occur in tumor cells responsible for aggressive subsets of neuroblastoma that relapse after chemotherapy. Neuroblastoma, a solid tumor of nerve tissue, is the most common cancer in infants, and its cure rates …

Read Full Story

National Network Leverages Electronic Records to Improve Care


In a special article recently published in Pediatrics, a research group led by The Children’s Hospital of Philadelphia’s Alexander G. Fiks, MD, MSCE, details the creation of a national “super network” devoted to comparative effectiveness research (CER). The network — the Comparative Effectiveness Research Through …

Read Full Story

Home Plate Study Hits the Ground Running on Healthy Food Prep


Nearly one in three children are considered to be overweight or obese in the U.S. What these children have on their plates at home today can affect their health for tomorrow. Senbagam Virudachalam MD, MSHP, faculty member at The Children’s Hospital of Philadelphia’s PolicyLab, is …

Read Full Story

President Obama Appoints CHOP Oncologist to National Cancer Board


Peter C. Adamson, MD, a pediatric oncologist and leading scientist at The Children’s Hospital of Philadelphia, and a professor of Pediatrics and Pharmacology at the Perelman School of Medicine at the University of Pennsylvania, has been appointed by President Obama to the National Cancer Advisory …

Read Full Story

Experts Target Mitochondrial Dysfunction After Pediatric TBI


Pediatric traumatic brain injury (TBI) will become a major cause of death and disability of children within the next several years, The World Health Organization predicts, as many third-world countries become urbanized. Whether the injuries result from motor vehicle crashes on the road or sports …

Read Full Story

New Ways Needed to Predict, Treat Relapsed Leukemia


Bench-to-bedside research at The Children’s Hospital of Philadelphia involves talented scientists who make discoveries in the lab that translate into investigations of clinical applications. CHOP experts studying T-cell acute lymphoblastic leukemia (T-ALL) are taking this model one step further — bench to bedside and back …

Read Full Story

Steven Douglas, MD, Honored as Paradigm Builder in HIV Neurovirology


The way viruses can infect the nervous system is at the heart of neurovirology, an important field of study that includes not only neuroscience and virology, but also molecular biology and immunology. Steven D. Douglas, MD, chief of the Section of Immunology at The Children’s …

Read Full Story

Vismodegib’s Activity Tested in Medulloblastoma Subgroups


Researchers’ understanding of the molecular pathways involved in cancer has enabled the development of targeted drugs for diseases such as pediatric and adult recurrent medulloblastoma, a type of rare brain cancer. Two studies reported in the Journal of Clinical Oncology assessed the efficacy of a …

Read Full Story

Young Adults Find Selecting Health Insurance Plans Confusing


While young adults are essential to the implementation of the Affordable Care Act (ACA), the process of applying for health insurance using the federal insurance marketplace HealthCare.gov can be confusing to them, according to a small, observational study. Historically, a significant part of the young …

Read Full Story

Share This